Mackenzie Financial’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $24.9M | Buy |
441,444
+66,377
| +18% | +$3.87M | 0.03% | 369 |
|
|
2025
Q4 | $22.1M | Buy |
375,067
+199,840
| +114% | +$10.9M | 0.03% | 371 |
|
|
2025
Q3 | $9.49M | Buy |
175,227
+53,164
| +44% | +$3.04M | 0.01% | 511 |
|
|
2025
Q2 | $6.71M | Buy |
122,063
+53,798
| +79% | +$3.17M | 0.01% | 546 |
|
|
2025
Q1 | $4.83M | Sell |
68,265
-152,396
| -69% | -$10.3M | 0.01% | 590 |
|
|
2024
Q4 | $14.5M | Buy |
220,661
+147,927
| +203% | +$9.91M | 0.02% | 411 |
|
|
2024
Q3 | $5.11M | Buy |
72,734
+42,260
| +139% | +$3.53M | 0.01% | 539 |
|
|
2024
Q2 | $2.51M | Buy |
30,474
+4,832
| +19% | +$402K | ﹤0.01% | 684 |
|
|
2024
Q1 | $2.24M | Sell |
25,642
-9,980
| -28% | -$893K | ﹤0.01% | 724 |
|
|
2023
Q4 | $3.43M | Sell |
35,622
-674
| -2% | -$59.6K | 0.01% | 627 |
|
|
2023
Q3 | $3.13M | Buy |
36,296
+6,280
| +21% | +$559K | 0.01% | 631 |
|
|
2023
Q2 | $2.58M | Sell |
30,016
-15,720
| -34% | -$1.48M | ﹤0.01% | 676 |
|
|
2023
Q1 | $4.45M | Buy |
45,736
+800
| +2% | +$82.9K | 0.01% | 570 |
|
|
2022
Q4 | $4.65M | Buy |
44,936
+2,165
| +5% | +$203K | 0.01% | 530 |
|
|
2022
Q3 | $3.63M | Sell |
42,771
-31,204
| -42% | -$2.78M | 0.01% | 575 |
|
|
2022
Q2 | $6.13M | Sell |
73,975
-41,988
| -36% | -$3.34M | 0.01% | 513 |
|
|
2022
Q1 | $8.94M | Sell |
115,963
-3,671
| -3% | -$307K | 0.01% | 479 |
|
|
2021
Q4 | $10.6M | Buy |
119,634
+34,580
| +41% | +$2.85M | 0.01% | 469 |
|
|
2021
Q3 | $6.57M | Buy |
85,054
+25,620
| +43% | +$2.02M | 0.01% | 525 |
|
|
2021
Q2 | $4.96M | Sell |
59,434
-1,786
| -3% | -$142K | 0.01% | 562 |
|
|
2021
Q1 | $4.62M | Buy |
61,220
+53,279
| +671% | +$4.35M | 0.01% | 551 |
|
|
2020
Q4 | $696K | Buy |
7,941
+1,003
| +14% | +$79.5K | ﹤0.01% | 763 |
|
|
2020
Q3 | $528K | Buy |
6,938
+1,886
| +37% | +$191K | ﹤0.01% | 781 |
|
|
2020
Q2 | $623K | Buy |
5,052
+1,106
| +28% | +$110K | ﹤0.01% | 763 |
|
|
2020
Q1 | $333K | Buy |
+3,946
| New | +$340K | ﹤0.01% | 876 |
|
|
2019
Q2 | – | Sell |
-46,057
| Closed | -$4.09M | – | 1106 |
|
|
2019
Q1 | $4.09M | Sell |
46,057
-64,523
| -58% | -$5.98M | 0.01% | 586 |
|
|
2018
Q4 | $9.42M | Buy |
+110,580
| New | +$10.5M | 0.02% | 378 |
|
|
2016
Q3 | – | Sell |
-12,138
| Closed | -$944K | – | 676 |
|
|
2016
Q2 | $944K | Buy |
12,138
+138
| +1% | +$11.7K | 0.01% | 611 |
|
|
2016
Q1 | $990K | Buy |
12,000
+2,600
| +28% | +$212K | 0.01% | 511 |
|
|
2015
Q4 | $985K | Buy |
9,400
+300
| +3% | +$31.3K | 0.01% | 539 |
|
|
2015
Q3 | $958K | Buy |
9,100
+1,100
| +14% | +$147K | 0.01% | 545 |
|
|
2015
Q2 | $1.09M | Buy |
8,000
+200
| +3% | +$24.8K | 0.01% | 539 |
|
|
2015
Q1 | $972K | Sell |
7,800
-40,500
| -84% | -$4.29M | 0.01% | 557 |
|
|
2014
Q4 | $4.37M | Sell |
48,300
-51,600
| -52% | -$4.29M | 0.02% | 334 |
|
|
2014
Q3 | $7.21M | Buy |
99,900
+6,500
| +7% | +$427K | 0.04% | 282 |
|
|
2014
Q2 | $5.81M | Buy |
93,400
+1,200
| +1% | +$72.5K | 0.03% | 316 |
|
|
2014
Q1 | $6.29M | Buy |
92,200
+3,800
| +4% | +$280K | 0.03% | 301 |
|
|
2013
Q4 | $6.22M | Buy |
88,400
+3,000
| +4% | +$204K | 0.03% | 286 |
|
|
2013
Q3 | $6.16M | Sell |
85,400
-25,700
| -23% | -$1.71M | 0.03% | 286 |
|
|
2013
Q2 | $6.19M | Buy |
+111,100
| New | +$6.92M | 0.03% | 296 |
|
Other funds holding BMRN
VCM
VPM
